Entris' DurAVR THV demonstrates 1% in-hospital heart failure, single-digit rates, and no valve-related deaths at 1 year in patients with small aortic stenosis.
Entris' DurAVR THV demonstrates 1% in-hospital heart failure, single-digit rates, and no valve-related deaths at 1 year in patients with small aortic stenosis.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in